PT  - JOURNAL ARTICLE
AU  - Masashi Kishi
AU  - Joe Henry Steinbach
TI  - Role of the Agonist Binding Site in Up-Regulation of Neuronal Nicotinic α4β2 Receptors
AID  - 10.1124/mol.106.029298
DP  - 2006 Dec 01
TA  - Molecular Pharmacology
PG  - 2037--2044
VI  - 70
IP  - 6
4099  - http://molpharm.aspetjournals.org/content/70/6/2037.short
4100  - http://molpharm.aspetjournals.org/content/70/6/2037.full
SO  - Mol Pharmacol2006 Dec 01; 70
AB  - Long-term exposure to nicotinic ligands results in up-regulation of neuronal nicotinic α4β2 receptors in the brain and in heterologous expression systems. Up-regulation can be produced by a variety of drugs, including nicotinic agonists and competitive antagonists, but previous studies have indicated that the signal for up-regulation does not reflect a traditional nicotinic pharmacology, and the initial steps in signal transduction are not clear. We examined the signal for up-regulation and the possible involvement of the nicotine binding site in signal reception using mutated subunits transiently expressed in human embryonic kidney 293 cells. The data indicate that receptor activation and desensitization are not part of the signaling pathway. However, mutations to residues in the binding site can affect up-regulation. These results provide evidence that the binding site is directly involved in receiving the signal for up-regulation. The American Society for Pharmacology and Experimental Therapeutics